COMMUNIQUÉS West-GlobeNewswire

Biotricity Actively Pursues Holter Market with Bioflux Product Offering

04/12/2018 - 14:00

Company Leverages Connectivity-Enabled Holter Capability to Expand Market Reach REDWOOD CITY, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY ), a medical diagnostic and consumer healthcare [...]

NexImmune Completes Sr. Leadership Team with New VP Hires

04/12/2018 - 14:00

Naimish Pandya, MD assumes role of VP & Head, Clinical Development Alex Matschiner, MS ChE assumes role of VP, Protein Process Development GAITHERSBURG, Md., Dec. 04, 2018 (GLOBE NEWSWIRE) -- NexImmune, an emerging [...]

Media Advisory: Canadian Blood Services board meeting open to the public

04/12/2018 - 14:00

OTTAWA, Dec. 04, 2018 (GLOBE NEWSWIRE) -- On December 6, Canadian Blood Services will open its doors physically and virtually, by live streaming its open board meeting at blood.ca, and inviting the public to attend in [...]

Avis aux médias : Le conseil d’administration de la Société canadienne du sang ouvre sa prochaine réunion au public

04/12/2018 - 14:00

OTTAWA, 04 déc. 2018 (GLOBE NEWSWIRE) -- La Société canadienne du sang invite la population à assister, en personne ou en ligne, à la réunion du conseil d’administration qui aura lieu au siège social de l’organisation, [...]

BioSyent Announces Normal Course Issuer Bid

04/12/2018 - 14:00

TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the Company’s Notice of Intention to Make [...]

Caelum Biosciences Announces Two Oral Presentations of Additional Data from Phase 1b Study of Anti-Amyloid mAb CAEL-101 and Preclinical Imaging Study at 60th American Society of Hematology Annual Meeting

04/12/2018 - 14:00

Phase 1b data confirm efficacy in AL Amyloidosis with two cardiac markers correlated with survival Preclinical data demonstrate the potential of using radiolabeled CAEL-101 for real-time imaging of human amyloidosis in [...]

aTyr Pharma Announces Initiation of Phase 1b/2a Study of ATYR1923 in Patients with Pulmonary Sarcoidosis and Collaboration with the Foundation for Sarcoidosis Research (FSR)

04/12/2018 - 14:00

FSR Clinical Studies Network to assist with clinical site initiation to expedite patient enrollment SAN DIEGO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the [...]

Nu-Med Plus, Inc. President Helps Lead Call for New Innovation in Inhaled Nitric Oxide Industry

04/12/2018 - 14:00

Nu-Med Plus President Jeff Robins published an open letter calling for greater awareness of inhaled nitric oxide to potentially advance treatment options for malaria, COPD, tuberculosis and ARDS SALT LAKE CITY, Dec. 04 [...]

Progressive Care Inc. Garners International News Coverage in Leading Trade Publications for Its Efforts to Improve Adherence

04/12/2018 - 14:00

MIAMI, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top [...]

BrainStorm Cell Therapeutics to Present at the 29th International Symposium on ALS/MND

04/12/2018 - 14:00

Poster highlights enrichment strategies for clinical trials in ALS NEW YORK, Dec. 04, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative autologous adult stem [...]

Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court

04/12/2018 - 13:50

Massachusetts Institute of Technology and Versitech Limited patent, licensed exclusively by Arch, is maintained without amendment as prior lower court decision is affirmed. FRAMINGHAM, Mass., Dec. 04, 2018 (GLOBE [...]

Moleculin Announces Breakthrough Discovery for its WP1066

04/12/2018 - 13:30

WP1066 shown to counteract resistance to checkpoint blockades HOUSTON, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company [...]

OpGen Receives Regulatory Approval to Market Pathogen Identification Products in Colombia

04/12/2018 - 13:30

Approval gives OpGen its first commercial product in the region; paves way for broader expansion into South American markets GAITHERSBURG, Md., Dec. 04, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced [...]

Marinus Pharmaceuticals Phase 2 Clinical Trial Data Show Long-term Effectiveness of Ganaxolone in Reducing Seizure Frequency in CDKL5 Deficiency Disorder Patients

04/12/2018 - 13:30

Predictive biomarker also identified in PCDH19-related pediatric epilepsy RADNOR, Pa., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical [...]

TG Therapeutics, Inc. Announces Follow-Up Data from the Triple Combination of Ublituximab, Umbralisib, and Bendamustine in Patients with DLBCL and FL at 60th American Society of Hematology Annual Meeting and Exposition

04/12/2018 - 13:30

NEW YORK, Dec. 04, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced updated clinical data from its Phase I/Ib trial of ublituximab (TG-1101), the Company’s novel glycoengineered anti-CD20 [...]

Dermira Enters into Credit Facility with Athyrium Capital Management

04/12/2018 - 13:30

Facility provides additional financial flexibility in connection with ongoing QBREXZA launch and lebrikizumab program MENLO PARK, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a [...]

Lenzilumab Data Presented in Oral Presentation at the American Society of Hematology (ASH)

04/12/2018 - 13:30

Lenzilumab (an anti-GM-CSF antibody) in combination with CAR-T cell therapy prevents cytokine release syndrome and neuroinflammation while improving durable control of leukemic disease Exponential increase in T cell [...]

ExCellThera announces results of clinical trial using ECT-001 for blood cancers

04/12/2018 - 13:05

MONTREAL, Dec. 04, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, today announced results from [...]

Tetra Bio-Pharma Convenes First National Medical Advisory Board

04/12/2018 - 13:00

Key Opinion Leaders Weigh in on Scientific Research in Cannabinoids ORLEANS, Ontario, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc (“ Tetra ” or “ TBP ”), (TSX VENTURE: TBP) (OTCQB: TBPMF), – announced that it [...]